These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin. Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702 [TBL] [Abstract][Full Text] [Related]
3. Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. Ren S; Lawson AE; Carr M; Baumgarten CM; Schwartz LB J Immunol; 1997 Oct; 159(7):3540-8. PubMed ID: 9317153 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure. Selwood T; McCaslin DR; Schechter NM Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324 [TBL] [Abstract][Full Text] [Related]
5. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase. Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554 [TBL] [Abstract][Full Text] [Related]
6. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase. Cregar L; Elrod KC; Putnam D; Moore WR Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872 [TBL] [Abstract][Full Text] [Related]
8. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin. Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069 [TBL] [Abstract][Full Text] [Related]
9. Expression and characterization of recombinant gamma-tryptase. Yuan J; Beltman J; Gjerstad E; Nguyen MT; Sampang J; Chan H; Janc JW; Clark JM Protein Expr Purif; 2006 Sep; 49(1):47-54. PubMed ID: 16815034 [TBL] [Abstract][Full Text] [Related]
10. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. Schechter NM; Brass LF; Lavker RM; Jensen PJ J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924 [TBL] [Abstract][Full Text] [Related]
11. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase. Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703 [TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic assay for tryptase based on the hydrolysis of dansyl-vasoactive intestinal peptide. Delaria K; Muller D Anal Biochem; 1996 Apr; 236(1):74-81. PubMed ID: 8619498 [TBL] [Abstract][Full Text] [Related]
13. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Imamura T; Dubin A; Moore W; Tanaka R; Travis J Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782 [TBL] [Abstract][Full Text] [Related]
14. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases. Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115 [TBL] [Abstract][Full Text] [Related]
15. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Pereira PJ; Bergner A; Macedo-Ribeiro S; Huber R; Matschiner G; Fritz H; Sommerhoff CP; Bode W Nature; 1998 Mar; 392(6673):306-11. PubMed ID: 9521329 [TBL] [Abstract][Full Text] [Related]
16. pH dependence of bovine mast cell tryptase catalytic activity and of its inhibition by 4',6-diamidino-2-phenylindole. Fiorucci L; Erba F; Bolognesi M; Coletta M; Ascoli F FEBS Lett; 1997 May; 408(1):85-8. PubMed ID: 9180274 [TBL] [Abstract][Full Text] [Related]
17. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors. He SH; Chen P; Chen HQ Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943 [TBL] [Abstract][Full Text] [Related]
18. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract. Hochstrasser K; Gebhard W; Albrecht G; Rasp G; Kastenbauer E Eur Arch Otorhinolaryngol; 1993; 249(8):455-8. PubMed ID: 8442939 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor. Scarpi D; McBride JD; Leatherbarrow RJ Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150 [TBL] [Abstract][Full Text] [Related]
20. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Fukuoka Y; Schwartz LB Biochemistry; 2004 Aug; 43(33):10757-64. PubMed ID: 15311937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]